Merck Income from Continuous Operations 2012-2026 | MRK

Merck income from continuous operations for the twelve months ending March 31, 2026 was $8.934B, a 48.81% decline year-over-year.

  • Merck annual income from continuous operations for 2025 was $18.263B, a 6.6% increase from 2024.
  • Merck annual income from continuous operations for 2024 was $17.133B, a 4444.56% increase from 2023.
  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.

Merck Income from Continuous Operations 2012-2026 | MRK

  • Merck annual income from continuous operations for 2025 was $18.263B, a 6.6% increase from 2024.
  • Merck annual income from continuous operations for 2024 was $17.133B, a 4444.56% increase from 2023.
  • Merck annual income from continuous operations for 2023 was $0.377B, a 97.4% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B